Study Stopped
Another study published with similar results
Timing of B and O Suppositories to Help Relieve Post-operative Bladder Spasms
1 other identifier
interventional
23
1 country
1
Brief Summary
Ureteroscopy is a common procedure in Urology that patients undergo daily to deal with a variety of ailments. These procedures often require that the bladder be filled and emptied with sterile water or saline several times during the procedure, and often result in the patient receiving a catheter at the end of the procedure. One common side effect is that patients experience bladder spasm or discomfort for a period of time after these procedures. Belladonna and Opium (B and O) suppositories and PO Oxybutynin are often given in the post-operative setting to relieve these symptoms. The principle objectives of this study are:
- 1.To determine if the addition of a B and O supprette suppository at the end of cystoscopic/ureteroscopic procedures reduces the incidence of bladder spasms and urinary discomfort that patients experience in the post-operative setting.
- 2.To determine if using peri-operative B and O supprette suppositories reduces the need for pos-operative oral Ditropan and use of narcotic pain medications.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for phase_4
Started Mar 2016
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
February 17, 2016
CompletedStudy Start
First participant enrolled
March 1, 2016
CompletedFirst Posted
Study publicly available on registry
August 12, 2016
CompletedPrimary Completion
Last participant's last visit for primary outcome
June 1, 2017
CompletedStudy Completion
Last participant's last visit for all outcomes
June 1, 2017
CompletedResults Posted
Study results publicly available
February 20, 2019
CompletedFebruary 20, 2019
February 1, 2019
1.3 years
February 17, 2016
December 26, 2018
February 19, 2019
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Post-operative Morphine Equivalent Dose
No results collected on the post-operative morphine equivalent dose
24 hours
Secondary Outcomes (1)
Post-Operative Pain
24 hours
Study Arms (3)
Pre-operative Suppository
EXPERIMENTALA B\&O Suppository will be placed in the patient's rectum after the induction of anesthesia, but before the surgery.
Post-operative Suppository
ACTIVE COMPARATORA B\&O Suppository will be placed in the patient's rectum while still under anesthesia, but after the surgery.
Rectal Exam
PLACEBO COMPARATORPatient's will be given a rectal exam after the procedure but while still under anesthesia to serve as a placebo.
Interventions
Eligibility Criteria
You may qualify if:
- Patients undergoing lithotripsy procedure at GW Hospital
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Campbell Grantlead
Study Sites (1)
George Washington University
Washington D.C., District of Columbia, 20037, United States
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Results Point of Contact
- Title
- Dr. Patrick Mufarrij
- Organization
- George Washington University
Study Officials
- PRINCIPAL INVESTIGATOR
Patrick Mufarrij
George Washington University
Publication Agreements
- PI is Sponsor Employee
- Yes
Study Design
- Study Type
- interventional
- Phase
- phase 4
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- PARTICIPANT
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR INVESTIGATOR
- PI Title
- Urology Resident
Study Record Dates
First Submitted
February 17, 2016
First Posted
August 12, 2016
Study Start
March 1, 2016
Primary Completion
June 1, 2017
Study Completion
June 1, 2017
Last Updated
February 20, 2019
Results First Posted
February 20, 2019
Record last verified: 2019-02
Data Sharing
- IPD Sharing
- Will not share